Transcriptional dysregulation has emerged as a central pathogenic mechanism in Huntington's disease (HD), which is associated with neuropathological changes predominantly in the striatum. Here we demonstrate that expression of Bcl11b (a.k.a. CTIP2), a transcription factor exhibiting highly-enriched localization in adult striatum, is significantly decreased in HD cells, mouse models and human subjects and that overexpression of Bcl11b attenuates toxic effects of mutant huntingtin in cultured striatal neurons. We show that Bcl11b directly activates the proximal promoter regions of striatal-enriched genes and can increase mRNA levels of striatalexpressing genes. We further demonstrate an interaction between Bcl11b and huntingtin protein in cultured cells and brain homogenates from HD R6/1 and YAC72 transgenic mice. We propose that sequestration and/or decreased expression of Bcl11b in HD is responsible, at least in part, for the dysregulation of striatal gene expression observed in HD and may contribute to the specificity of pathology observed in this disease.
Introduction
Huntington's disease (HD) is an inherited, neurodegenerative disorder caused by expansion of a trinucleotide (CAG) repeat region in the HD gene, which results in an expanded polyglutamine stretch in the encoded protein, huntingtin (htt) (Group, 1993) . A major enigma exists regarding the pathology in HD: although the mutated htt protein is expressed ubiquitously throughout the brain and body, the most striking neurodegenerative changes are observed in the striatum, a brain region that regulates movement and directed motor behavior, as well as cognitive function (Graybiel, 2005) . Since the distribution of htt is itself inadequate to explain the regional patterns of pathology that ensues in HD, a major question exists regarding the mechanism(s) for this specificity.
Diverse models for HD cellular pathogenesis have been proposed (Ross, 2004) . However, increasing evidence implicates transcriptional dysregulation as a central pathogenic mechanism in HD (Cha, 2000; Okazawa 2003; Sugars and Rubinsztein, 2003) . The exact roles of htt in the regulation of transcription are not clear; however interactions between htt and several transcription factors have been demonstrated. Studies have shown that mutant htt interacts with ubiquitous transcription factors such as the cAMP response element-binding protein (CREB)-binding protein (CBP), Specificity protein 1 (Sp1), TATA binding box protein (TBP) and widely expressed components of the basal polymerase II transcriptional machinery such as the transcription initiation factor complexes TFIID and TFIIF, and the TATA box binding protein (TBP)-associated factor (TAF4; a.k.a. TAFII130) (McCampbell et al., 2000; Shimohata et al., 2000; Dunah et al., 2002; Li et al., 2002; van Roon-Mom et al., 2002; Zhai et al., 2005) . However, other mechanisms of transcription factor disruption due to mutant htt have been proposed (Chen-Plotkin et al., 2006; Sadri-Vakili et al., 2007) . Overall, there is much evidence that mutant htt disrupts transcriptional regulation; consequential of this concept are gene profiling studies that have revealed dramatic expression alterations of genes, especially those exhibiting enriched expression in the striatum, in the brains of HD mouse models and human subjects with HD (Luthi-Carter et al., 2000; Zucker et al., 2005; Desplats et al., 2006; Hodges et al., 2006; Thomas, 2006) .
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